FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Rejects Teva Copaxone Bioequivalence Petition

[ Price : $8.95]

FDA denies a Teva citizen petition that asked the agency to not approve any ANDA for its multiple sclerosis drug Copaxone (glatira...

FDA Drug SUPAC Manufacturing Equipment Change Addendum

[ Price : $8.95]

FDA posts a guidance on Scale-up Post-approval Changes: Manufacturing Equipment Addendum to help manufacturers determine the docum...

Guidance on Infusion Pump Submissions

[ Price : $8.95]

The agency posts a final guidance on Infusion Pumps Total Product Life Cycle to assist industry in preparing premarket submissions...

Medical Product Firms Being Hacked Over Sensitive Info

[ Price : $8.95]

An Internet security firm says it is currently tracking a group that targets the email accounts of senior employees at healthcare ...

Amarin Pharma Petition on Vascepa Rejected by FDA

[ Price : $8.95]

FDA denies an Amarin Pharmaceuticals Ireland petition asking it to impose specific bioequivalence testing requirements on any ANDA...

Class 1 Recall of Synthes Titanium Matrix Spine Screws

[ Price : $8.95]

Synthes begins a Class 1 recall of its Titanium Polyaxial Reduction Head for Titanium Matrix Spine Screws, reporting that two nonc...

FDA Accepts Ispen BLA for Dysport in Limb Spasticity

[ Price : $8.95]

FDA accepts for review an Ipsen BLA for Dysport (abobotulinumtoxinA) for use in treating upper limb spasticity in adult patients.

Info on Accredited Persons Inspection Sent to OMB

[ Price : $8.95]

Federal Register Notice: FDA sends a proposed collection of information on the accredited person inspection program to the Office ...

Info on Humanitarian Use Devices to OMB

[ Price : $8.95]

Federal Register Notice: FDA submits a proposed collection of information on humanitarian use devices to the Office of Management ...

Workshop Notice Amended

[ Price : $8.95]

Federal Register Notice: FDA amends a notice of an upcoming public workshop of the Sentinel Initiative.